For research teamsHelp me find a study
Back to all studies
Active Not RecruitingNCT06741228

DT120 Compared to Placebo for anxiety

This study is active but not recruiting in the United States. It is testing DT120 Compared to Placebo for anxiety.

AnxietyDrugFrom 18 Years to 74 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether DT120 may be useful for adults experiencing anxiety.

What would participation involve?

Participants may receive DT120, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with anxiety.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: December 11, 2024
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
214
Sponsor
Definium Therapeutics US, Inc.
Sponsor type
Biotech company
Study type
Drug
Intervention type
Medication / drug, OTHER
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 74 Years
Official registry ID
NCT06741228
Official title
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40-Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral DT120 Compared to Placebo in the Treatment of Adults With Generalized Anxiety Disorder - Voyage

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 34 sites
  • Lighthouse Psychiatry
    Gilbert, Arizona
    Site status: Not listed — confirm with the team
  • Scottsdale Research Institute
    Scottsdale, Arizona
    Site status: Not listed — confirm with the team
  • Kadima Neuropsychiatry Institute
    La Jolla, California
    Site status: Not listed — confirm with the team
  • UCSF Department of Neurology
    San Francisco, California
    Site status: Not listed — confirm with the team
  • Psychedelic Science Institute
    Santa Monica, California
    Site status: Not listed — confirm with the team
  • Mountain View
    Denver, Colorado
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions Inc.
    Jacksonville, Florida
    Site status: Not listed — confirm with the team
  • Segal Trials
    Lauderhill, Florida
    Site status: Not listed — confirm with the team
  • Atlanta Center for Medical Research
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • iResearch Atlanta
    Decatur, Georgia
    Site status: Not listed — confirm with the team
  • CenExel iResearch, LLC
    Savannah, Georgia
    Site status: Not listed — confirm with the team
  • Uptown Research Institute
    Chicago, Illinois
    Site status: Not listed — confirm with the team
  • Adams Clinical Boston
    Boston, Massachusetts
    Site status: Not listed — confirm with the team
  • Adams Clinical Watertown
    Watertown, Massachusetts
    Site status: Not listed — confirm with the team
  • Hassman Research Institute
    Marlton, New Jersey
    Site status: Not listed — confirm with the team
  • Spectrum Neuroscience and Treatment Institute
    New York, New York
    Site status: Not listed — confirm with the team
  • Adams Clinical Harlem
    New York, New York
    Site status: Not listed — confirm with the team
  • New York State Psychiatric Institute (NYSPI)
    New York, New York
    Site status: Not listed — confirm with the team
  • Adams Clinical Bronx
    The Bronx, New York
    Site status: Not listed — confirm with the team
  • Cleveland Clinic Lutheran Hospital
    Cleveland, Ohio
    Site status: Not listed — confirm with the team
  • Summit Headlands LLC
    Portland, Oregon
    Site status: Not listed — confirm with the team
  • Scranton Medical Institute
    Moosic, Pennsylvania
    Site status: Not listed — confirm with the team
  • Adams Clinical Philadelphia
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Coastal Carolina Research Center
    North Charleston, South Carolina
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions, Inc.
    Memphis, Tennessee
    Site status: Not listed — confirm with the team
  • University of Texas at Austin
    Austin, Texas
    Site status: Not listed — confirm with the team
  • Austin Clinical Trial Partners
    Austin, Texas
    Site status: Not listed — confirm with the team
  • BioBehavioral Research of Austin
    Austin, Texas
    Site status: Not listed — confirm with the team
  • FutureSearch Trials of Dallas, LLC
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Adams Clinical Dallas
    DeSoto, Texas
    Site status: Not listed — confirm with the team
  • Cedar Clinical Research
    Draper, Utah
    Site status: Not listed — confirm with the team
  • Inner Space Research
    Orem, Utah
    Site status: Not listed — confirm with the team
  • Memory Clinic Inc.
    Bennington, Vermont
    Site status: Not listed — confirm with the team
  • Seattle Neuropsychiatric Treatment Center
    Seattle, Washington
    Site status: Not listed — confirm with the team

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT06741228. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with anxiety. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Placebo, DT120. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with anxiety; age range: From 18 Years to 74 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Definium Therapeutics US, Inc., which appears to be a biotech company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.